Vigabatrin
Calli, J.; Farrington, E.
Pediatric Nursing 24(4): 357-361
1998
ISSN/ISBN: 0097-9805 PMID: 9849270 Document Number: 493102
Document emailed within 1 workday
Related Documents
Persson, L. 1988: CSF soluble proteins and vigabatrin British Journal of Clinical Practice. Suppl 61: 14-15Nakken, K.O.; Henriksen, O.; Johannessen, S.I. 1994: Vigabatrin--a new antiepileptic agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(24): 2843-2844
Dieterle, L.; Becker, E.W.; Berg, P.A.; Berkenfeld, R.; Reinshagen, G. 1994: Allergic vasculitis caused by Vigabatrin Der Nervenarzt 65(2): 122-124
Kankirawatana, P.; Raksadawan, N.; Balangkura, K. 2002: Vigabatrin therapy in infantile spasms Journal of the Medical Association of Thailand 85(Suppl): S778-S783
Monaco, F. 1996: Cognitive effects of vigabatrin: a review Neurology 47(1 Suppl 1): S6-S11
Tay, S.K.; Ong, H.T.; Low, P.S. 2001: The use of vigabatrin in infantile spasms in Asian children Annals of the Academy of Medicine Singapore 30(1): 26-31
Caviedes, B.E.; Herranz, J.L.; Arteaga, R.; Armijo, J.A. 1999: In children with refractory epilepsy: vigabatrin or lamotrigine? Revista de Neurologia 28(5): 444-448
Visudtibhan, A.; Chiemchanya, S.; Visudhiphan, P.; Phusirimongkol, S. 1999: Vigabatrin in infantile spasms: preliminary result Journal of the Medical Association of Thailand 82(10): 1000-1005
Nagarajan, L.; Schramm, T.; Appleton, D.B.; Burke, C.J.; Eadie, M.J. 1993: Plasma vigabatrin enantiomer ratios in adults and children Clinical and Experimental Neurology 30: 127-136
Sastre-Garau, P.; Thomas, P.; Beaussart, M.; Goudemand, M. 1993: Subsequent manic onset caused by association of vigabatrin-clomipramine L'Encephale 19(4): 351-352
Manuchehri, K. 2000: Visual field defect associated with vigabatrin. Method of estimating prevalence was inappropriate Bmj 320(7246): 1403-4; Author Reply 1404
Kita, S.; Nishimura, Y.; Togawa, M.; Maegaki, Y. 2016: Vigabatrin administration for infants and young children with intractable generalized epilepsy No to Hattatsu 48(4): 265-270
Elferink, A.J.; Toivonen, M.; van Bronswijk, H. 1999: Safety and efficacy of vigabatrin and carbamazepine. CPMP. The Committee for Proprietary Medicinal Products Lancet 354(9187): 1387-1388
Pfersmann, D.; Saletu, B.; Semlitsch, H.V.; Anderer, P.; Dieterich, H.A. 1993: Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients Wiener Medizinische Wochenschrift 143(6): 119-128
Lortie, A.; Chiron, C.; Mumford, J.; Dulac, O. 1993: The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin Neurology 43(11 Suppl 5: S24-S27